Genomic study identifies subgroups of breast cancer with varying sensitivities to treatment
Friday, January 17, 2014 - 14:50
in Health & Medicine
Researchers describe as many as four subgroups of HER2+ breast cancer with varying responses and benefits resulting from combined anti-HER2 targeted therapy and chemotherapy.